An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-...

por Fukui, Reiko, Watanabe, Takahiro, Morimoto, Koji, Fujimoto, Yukie, Nagahashi, Masayuki, Ishikawa, Eri, Hirota, Seiichi, Miyoshi, Yasuo
Publicado 2023

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

por Imamura, Michiko, Morimoto, Takashi, Egawa, Chiyomi, Fukui, Reiko, Bun, Ayako, Ozawa, Hiromi, Miyagawa, Yoshimasa, Fujimoto, Yukie, Higuchi, Tomoko, Miyoshi, Yasuo
Publicado 2019

Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in (18)F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Brea...

por Higuchi, Tomoko, Fujimoto, Yukie, Ozawa, Hiromi, Bun, Ayako, Fukui, Reiko, Miyagawa, Yoshimasa, Imamura, Michiko, Kitajima, Kazuhiro, Yamakado, Koichiro, Miyoshi, Yasuo
Publicado 2019

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer

por Miyagawa, Yoshimasa, Yanai, Ayako, Yanagawa, Takehiro, Inatome, Junichi, Egawa, Chiyomi, Nishimukai, Arisa, Takamoto, Kaori, Morimoto, Takashi, Kikawa, Yuichiro, Suwa, Hirofumi, Taji, Tomoe, Yamaguchi, Ai, Okada, Yuki, Sata, Atsushi, Fukui, Reiko, Bun, Ayako, Ozawa, Hiromi, Higuchi, Tomoko, Fujimoto, Yukie, Imamura, Michiko, Miyoshi, Yasuo
Publicado 2020